Nektar Therapeutics
NKTR
#6053
Rank
โ‚ฌ0.94 B
Marketcap
27,53ย โ‚ฌ
Share price
-7.19%
Change (1 day)
-47.38%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -5,76ย โ‚ฌ

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -6,11ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -9,30ย โ‚ฌ a decrease over its 2024 EPS that were of -8,08ย โ‚ฌ.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,76ย โ‚ฌ-38.07%
2025-9,30ย โ‚ฌ15.12%
2024-8,08ย โ‚ฌ-59.54%
2023-19,96ย โ‚ฌ-25.89%
2022-26,94ย โ‚ฌ-31.12%
2021-39,11ย โ‚ฌ14.86%
2020-34,05ย โ‚ฌ-1.19%
2019-34,46ย โ‚ฌ-163.96%
201853,88ย โ‚ฌ-725.4%
2017-8,61ย โ‚ฌ-42.73%
2016-15,04ย โ‚ฌ83.33%
2015-8,20ย โ‚ฌ39.53%
2014-5,88ย โ‚ฌ-69.29%
2013-19,14ย โ‚ฌ-6.67%
2012-20,51ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,65ย โ‚ฌ-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-1,29ย โ‚ฌ-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,91ย โ‚ฌ-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,49ย โ‚ฌ-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
0,55ย โ‚ฌ-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-0,0000000000ย โ‚ฌ-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland